AstraZeneca - NAI
FDA Inspections Database
AstraZeneca - NAI
FDA Inspections Database
U.S. FDA inspection classifications and citation records from the official FDA inspection database.
- Total Records 46
- Latest Inspection 2026-01-14
- Data Source U.S. FDA
- Last Updated 2026-04-02
Company Overview
Company
AstraZeneca - NAI
Country
United Kingdom
Website
Social Profiles
Company Snapshot
AstraZeneca - NAI
2 Kingdom Street, Paddington, London W2 6BD
United Kingdom
www.astrazeneca.com/ Russell.Gantt@astrazeneca.com View on MapFDA Inspections Timeline (46 records)
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2026-01-14
FMD Date
2026-04-02
Fiscal Year
2026
State
Maryland
Additional Details
Sponsor, Contract Research Organization
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2026
Citations: No
Legal Name
AstraZeneca AB
Project Area
Compliance: Devices
Product Type
Devices
Posted Citations
No
Inspection End Date
2025-11-13
FMD Date
-
Fiscal Year
2026
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2026
Citations: No
Legal Name
AstraZeneca AB
Project Area
Postmarket Assurance: Devices
Product Type
Devices
Posted Citations
No
Inspection End Date
2025-11-13
FMD Date
-
Fiscal Year
2026
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2026
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Vaccines and Allergenic Products
Product Type
Biologics
Posted Citations
No
Inspection End Date
2025-06-24
FMD Date
2025-08-25
Fiscal Year
2025
State
Pennsylvania
Location
Philadelphia, Pennsylvania, United States
Inspection Info
Fiscal Year: 2025
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2024-10-25
FMD Date
2025-01-16
Fiscal Year
2025
State
Maryland
Additional Details
Sponsor, Contract Research Organization
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2025
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2024-10-04
FMD Date
2025-03-12
Fiscal Year
2025
State
Delaware
Additional Details
Sponsor, Contract Research Organization
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2025
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2024-01-22
FMD Date
2024-03-07
Fiscal Year
2024
State
Maryland
Additional Details
Sponsor, Contract Research Organization
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2024
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2023-09-20
FMD Date
2024-04-04
Fiscal Year
2023
State
Delaware
Additional Details
Postmarket Adverse Drug Experience (PADE)
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2023
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2023-07-18
FMD Date
2023-10-19
Fiscal Year
2023
State
Maryland
Additional Details
Sponsor, Contract Research Organization
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2023
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2021-10-25
FMD Date
2021-11-17
Fiscal Year
2022
State
California
Location
Redwood City, California, United States
Inspection Info
Fiscal Year: 2022
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2021-09-30
FMD Date
2021-12-21
Fiscal Year
2021
State
Maryland
Additional Details
Sponsor, Contract Research Organization
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2021
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2021-02-26
FMD Date
2021-07-02
Fiscal Year
2021
State
Maryland
Additional Details
Sponsor, Contract Research Organization
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2021
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2020-10-27
FMD Date
2021-03-22
Fiscal Year
2021
State
Maryland
Additional Details
Sponsor, Contract Research Organization
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2021
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2018-10-11
FMD Date
-
Fiscal Year
2019
State
Maryland
Additional Details
Sponsor, Contract Research Organization
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2019
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2018-02-05
FMD Date
-
Fiscal Year
2018
State
Maryland
Additional Details
Sponsor, Contract Research Organization
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2018
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2017-05-18
FMD Date
2018-07-12
Fiscal Year
2017
State
Maryland
Additional Details
Sponsor, Contract Research Organization
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2017
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2017-01-27
FMD Date
2017-05-24
Fiscal Year
2017
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2017
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2016-12-09
FMD Date
2018-07-12
Fiscal Year
2017
State
Maryland
Additional Details
Sponsor, Contract Research Organization
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2017
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2016-03-10
FMD Date
-
Fiscal Year
2016
State
Colorado
Location
Denver, Colorado, United States
Inspection Info
Fiscal Year: 2016
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2016-01-28
FMD Date
-
Fiscal Year
2016
State
Indiana
Location
Mount Vernon, Indiana, United States
Inspection Info
Fiscal Year: 2016
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2015-09-29
FMD Date
-
Fiscal Year
2015
State
Maryland
Additional Details
Sponsor, Contract Research Organization
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2015
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2015-07-24
FMD Date
-
Fiscal Year
2015
State
Maryland
Location
Frederick, Maryland, United States
Inspection Info
Fiscal Year: 2015
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2015-06-19
FMD Date
-
Fiscal Year
2015
State
Delaware
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2015
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2015-06-19
FMD Date
-
Fiscal Year
2015
State
Delaware
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2015
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2015-06-19
FMD Date
-
Fiscal Year
2015
State
Delaware
Additional Details
Postmarket Adverse Drug Experience (PADE)
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2015
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2014-09-26
FMD Date
2015-03-24
Fiscal Year
2014
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2014
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2014-08-26
FMD Date
-
Fiscal Year
2014
State
Delaware
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2014
Citations: No
Legal Name
AstraZeneca LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2014-07-23
FMD Date
-
Fiscal Year
2014
State
Massachusetts
Location
Westborough, Massachusetts, United States
Inspection Info
Fiscal Year: 2014
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2014-04-07
FMD Date
-
Fiscal Year
2014
State
Delaware
Additional Details
Sponsor, Contract Research Organization
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2014
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2013-04-12
FMD Date
-
Fiscal Year
2013
State
Delaware
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2013
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2012-09-27
FMD Date
-
Fiscal Year
2012
State
Delaware
Additional Details
Postmarket Adverse Drug Experience (PADE)
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2012
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2012-09-21
FMD Date
-
Fiscal Year
2012
State
Maryland
Location
Frederick, Maryland, United States
Inspection Info
Fiscal Year: 2012
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2012-09-13
FMD Date
-
Fiscal Year
2012
State
Indiana
Location
Mount Vernon, Indiana, United States
Inspection Info
Fiscal Year: 2012
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2012-06-18
FMD Date
-
Fiscal Year
2012
State
Delaware
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2012
Citations: No
Legal Name
AstraZeneca LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2012-06-14
FMD Date
-
Fiscal Year
2012
State
Massachusetts
Location
Westborough, Massachusetts, United States
Inspection Info
Fiscal Year: 2012
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2012-06-07
FMD Date
-
Fiscal Year
2012
State
Delaware
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2012
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2012-05-29
FMD Date
2013-02-04
Fiscal Year
2012
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2012
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2012-05-29
FMD Date
2013-02-04
Fiscal Year
2012
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2012
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2011-08-12
FMD Date
-
Fiscal Year
2011
State
Indiana
Location
Mount Vernon, Indiana, United States
Inspection Info
Fiscal Year: 2011
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2010-12-09
FMD Date
2011-07-20
Fiscal Year
2011
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2011
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2010-03-25
FMD Date
2010-08-13
Fiscal Year
2010
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2010
Citations: No
Legal Name
AstraZeneca AB
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2010-03-19
FMD Date
2010-08-13
Fiscal Year
2010
State
Location
Sodertalje, , Sweden
Inspection Info
Fiscal Year: 2010
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2010-02-03
FMD Date
-
Fiscal Year
2010
State
Indiana
Location
Mount Vernon, Indiana, United States
Inspection Info
Fiscal Year: 2010
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2009-09-17
FMD Date
-
Fiscal Year
2009
State
Delaware
Additional Details
Postmarket Adverse Drug Experience (PADE)
Location
Wilmington, Delaware, United States
Inspection Info
Fiscal Year: 2009
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2009-06-18
FMD Date
-
Fiscal Year
2009
State
Maryland
Location
Frederick, Maryland, United States
Inspection Info
Fiscal Year: 2009
Citations: No
Legal Name
AstraZeneca Pharmaceuticals LP
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2009-01-29
FMD Date
-
Fiscal Year
2009
State
Indiana
Location
Mount Vernon, Indiana, United States
Inspection Info
Fiscal Year: 2009
Citations: No
Classification Breakdown
46 total- NAI (No Action Indicated)
Official Source
All data is sourced from the official FDA inspection database maintained by the U.S. Food and Drug Administration.
Visit FDA.govRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Location
Gaithersburg, Maryland, United States
Inspection Info
Fiscal Year: 2026
Citations: No
100% Official Data
Directly from the U.S. FDA inspection database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.